Stock UniverseDerived research view · source repositories remain read-only

OPKO Health, Inc. (OPK)

Life Science Tools / Diagnostics / MedTech · Healthcare / Diagnostics & Research
Score Band
Watch
Selection Score
30.80
Global Rank
1848
Market Cap
921.24M
Latest Close
1.44
RS Composite
10.29% · G#747

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
28.57%
3M
22.03%
6M
5.11%
1Y
6.67%
3Y
3.60%
5Y
-62.30%
10Y
-86.45%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 3.94M · 30-day average: 2.82M · Max drawdown over stored range: -92.70%

Research Snapshot

Relative Strength vs SPX

RS Composite10.29%
20D RS27.94%
60D RS15.17%
120D RS-3.40%
Global RS Rank747 · 77.73% percentile
Watch+Speculative RS Rank461 · 78.02% percentile
Group ScopeWatch+Speculative
Primary RS Rank22 · 84.51% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank98 / 246
Primary Percentile60.57
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-04-28581.12M209.08M-101.26M-212.91M-0.28-315.83M20.59M-336.41M773M35.98%-17.42%-36.64%-54.35%-57.89%331.86M2.01M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-0.28-5.2x$0.751.9x$-0.44-3.3x$-0.41-3.5x

Shares Diluted: 773M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue1435.4131774.7181004.196863.495713.142606.879
Revenue Growth (YoY)59.148%23.638%-43.417%-14.011%-17.412%-14.901%
Gross Profit465.689504.674214.332228.534113.29681.907
Operating Income53.725-14.461-246.124-158.057-273.558-218.985
Free Cash Flow5.7946.181-119.767-44.472-208.499-190.82
Free Cash Flow Per Share0.0090.01-0.167-0.059-0.3-0.254
EPS (Diluted) GAAP0.047741-0.046511-0.456713-0.251225-0.076689-0.300452
EPS Growth
EPS Non-GAAP
Gross Margin32.443%28.437%21.344%26.466%15.887%13.496%
Operating Margin3.743%-0.815%-24.51%-18.304%-38.36%-36.084%
Profit Margin2.131%-1.698%-32.703%-21.872%-7.463%-37.187%
Free Cash Flow Margin0.404%0.348%-11.927%-5.15%-29.237%-31.443%
Shares Outstanding (Diluted)640.6553648.0777719.0609751.7659694.0195751.1329
Shares Change (YoY)7.591%1.159%10.953%4.548%-7.681%8.229%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-04-28124.20M36.84%-51.02M-41.08%-54.85M-44.16%-0.07758.88M331.86M2.01Mprocessed
2025 Q42026-02-26148.45M43.13%-38.32M-25.81%-31.26M-21.06%-0.04766.12M364.41M2.26Mprocessed
2025 Q32025-10-29151.67M32.90%48.06M31.68%21.63M14.26%0.03779.92M411.97M2.51Mprocessed
2025 Q22025-07-31156.81M31.50%-59.98M-38.25%-148.44M-94.66%-0.19788.01M267.28M2.77Mprocessed
2025 Q12025-05-01149.95M28.42%-67.17M-44.79%-67.61M-45.09%n/an/a428.83M2.83Mprocessed
2024 Q42025-03-03183.64Mn/a-33.14M-18.05%14.03M7.64%n/an/a426.58M3.00Mprocessed
2024 Q32024-11-07173.63Mn/a14.22M8.19%24.89M14.33%0.03998.36M400.08M3.53Mprocessed
2024 Q22024-08-07182.19Mn/a-61.67M-33.85%-10.30M-5.66%n/an/a40.58M3.68Mprocessed
2024 Q12024-05-07173.69Mn/a-71.47M-41.15%-81.84M-47.12%n/an/a75.64M4.04Mprocessed
2023 Q42024-03-01181.90Mn/a-69.05M-37.96%-66.48M-36.55%n/an/a95.88M7.73Mprocessed
2023 Q32023-11-06178.59Mn/a-64.41M-36.06%-84.47M-47.30%n/an/a138.62M7.93Mprocessed
2023 Q22023-08-03265.42Mn/a7.03M2.65%-19.64M-7.40%n/an/a108.11M8.50Mprocessed
2023 Q12023-05-03237.58Mn/a-30.59M-12.88%-18.27M-7.69%-0.02751.51M110.83M244.64Mprocessed
2022 Q42023-02-27185.34Mn/a-55.27M-29.82%-85.23M-45.99%-0.11751.88M153.19M256.25Mprocessed
2022 Q32022-11-08179.74Mn/a-87.82M-48.86%-86.09M-47.90%-0.11750.40M180.84M244.98Mprocessed
2022 Q22022-08-04309.89Mn/a-10.74M-3.47%-101.65M-32.80%-0.14712.55M210.46M232.45Mprocessed
2022 Q12022-05-09329.22Mn/a-72.42M-22.00%-55.43M-16.84%-0.08660.30M102.28M230.26Mprocessed
2021 Q42022-03-01401.33Mn/a-63.08M-15.72%-73.77M-18.38%-0.11652.18M134.71M205.27Mprocessed
2021 Q32021-10-28385.81Mn/a37.83M9.80%28.74M7.45%0.04651.84M148.60M1.67Mprocessed
2021 Q22021-07-29442.41Mn/a5.57M1.26%-16.19M-3.66%-0.03647.00M65.76M3.97Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.